CN Patent

CN110141557A — 氢化可的松控制释放制剂

Assigned to Immedica UK Ltd · Expires 2019-08-20 · 7y expired

What this patent protects

本公开涉及包含氢化可的松的药物制剂及其在治疗疾病状况中的应用，所述疾病状况为受益于氢化可的松的延迟释放的疾病状况，特别是诸如肾上腺功能不全、炎性状况和抑郁症的疾病状况。

USPTO Abstract

本公开涉及包含氢化可的松的药物制剂及其在治疗疾病状况中的应用，所述疾病状况为受益于氢化可的松的延迟释放的疾病状况，特别是诸如肾上腺功能不全、炎性状况和抑郁症的疾病状况。

Drugs covered by this patent

Patent Metadata

Patent number
CN110141557A
Jurisdiction
CN
Classification
—
Expires
2019-08-20
Drug substance claim
No
Drug product claim
No
Assignee
Immedica UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.